Remote monitoring for patients with Chronic Obstructive Pulmonary Disease
Evaluation of the Use of a Remote Monitoring and Follow-up Option for Patients With Chronic Obstructive Pulmonary Disease
This study is testing a remote monitoring system to see if it can help people with COPD catch worsening symptoms early and improve their health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT05759247 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the Bora Care remote monitoring solution in detecting early acute exacerbations of Chronic Obstructive Pulmonary Disease (COPD). It aims to validate the use of telemonitoring tools to track various parameters such as cardio-respiratory metrics, environmental factors, and symptom questionnaires. By identifying exacerbations early, the study seeks to improve patient outcomes and reduce healthcare costs associated with COPD management.
Who should consider this trial
Good fit: Ideal candidates include patients with COPD who have experienced multiple exacerbations in the past year and are currently stable enough to participate.
Not a fit: Patients with unstable comorbidities or those unable to use the monitoring tool may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and treatment of COPD exacerbations, improving patient quality of life and reducing hospitalizations.
How similar studies have performed: Other studies have shown promise in using telemonitoring for COPD management, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with COPD defined according to the SPLF recommendations, whose level of lung function in a stable state is known (measurement less than 12 months old) * Patient with at least one of the following criteria : * Hospitalized for a COPD exacerbation at the time of enrolment in the study, and having had at least one other exacerbation in the last 12 months * Followed-up and part of the active file of the site, having had at least 2 exacerbations during the last 12 months, including one with hospitalization * COPD patient with at least 2 exacerbations in the last 12 months, including one with hospitalization * Patient having given written informed consent to participate in the study * Patient affiliated to the French social security system Exclusion Criteria * Vulnerable patient (minor, protected adult, prisoner) * Patient unable to use the BoraBand tool and without access to a caregiver * Presence of a comorbidity considered unstable or very severe by the investigator * Patient already participating in another interventional research study
Where this trial is running
Paris
- Pneumology Department - Hôpital Cochin — Paris, France (Recruiting)
Study contacts
- Principal investigator: Nicolas ROCHE, MD, PhD — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Nicolas ROCHE, MD, PhD
- Email: nicolas.roche@aphp.fr
- Phone: 01 58 41 21 53
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.